Eistland - eistneska - Ravimiamet

alembic pharmaceuticals europe limited - telmisartaan+amlodipiin - tablett - 80mg+5mg 360tk; 80mg+5mg 30tk; 80mg+5mg 28tk; 80mg+5mg 10tk; 80mg+5mg 56tk; 80mg+5mg 14tk; 80mg+5mg 90tk

Eistland - eistneska - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 200mg 56tk; 200mg 28tk; 200mg 168tk; 200mg 14tk

Eistland - eistneska - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 50mg 168tk; 50mg 56tk; 50mg 28tk; 50mg 14tk

Eistland - eistneska - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 150mg 28tk; 150mg 168tk; 150mg 14tk

Eistland - eistneska - Ravimiamet

sandoz pharmaceuticals d.d. - sorafeniib - õhukese polümeerikattega tablett - 400mg 84tk; 400mg 56tk; 400mg 112tk; 400mg 30tk; 400mg 28tk

Eistland - eistneska - Ravimiamet

sandoz pharmaceuticals d.d. - agomelatiin - õhukese polümeerikattega tablett - 25mg 14tk; 25mg 7tk; 25mg 42tk; 25mg 28tk; 25mg 84tk; 25mg 98tk; 25mg 56tk; 25mg 100tk

Eistland - eistneska - Ravimiamet

aop orphan pharmaceuticals gmbh - tadalafiil - õhukese polümeerikattega tablett - 20mg 28tk; 20mg 56tk

Eistland - eistneska - Ravimiamet

alembic pharmaceuticals europe limited - duloksetiin - gastroresistentne kõvakapsel - 20mg 28tk; 20mg 56tk; 20mg 98tk

Eistland - eistneska - Ravimiamet

alembic pharmaceuticals europe limited - duloksetiin - gastroresistentne kõvakapsel - 40mg 28tk; 40mg 56tk; 40mg 98tk

Evrópusambandið - eistneska - EMA (European Medicines Agency)

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.